Skip to main content
Top
Published in: Cancer Causes & Control 3/2008

Open Access 01-04-2008 | Original Paper

Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.

Authors: Barry A. Miller, Kenneth C. Chu, Benjamin F. Hankey, Lynn A. G. Ries

Published in: Cancer Causes & Control | Issue 3/2008

Login to get access

Abstract

Objectives

We report cancer incidence, mortality, and stage distributions among Asians and Pacific Islanders (API) residing in the U.S. and note health disparities, using the cancer experience of the non-Hispanic white population as the referent group. New databases added to publicly available SEER*Stat software will enable public health researchers to further investigate cancer patterns among API groups.

Methods

Cancer diagnoses among API groups occurring from 1 January 1998 to 31 December 2002 were included from 14 Surveillance, Epidemiology, and End Results (SEER) Program state and regional population-based cancer registries covering 54% of the U.S. API population. Cancer deaths were included from the seven states that report death information for detailed API groups and which cover over 68% of the total U.S. API population. Using detailed racial/ethnic population data from the 2000 decennial census, we produced incidence rates centered on the census year for Asian Indians/Pakistanis, Chinese, Filipinos, Guamanians, Native Hawaiians, Japanese, Kampucheans, Koreans, Laotians, Samoans, Tongans, and Vietnamese. State vital records offices do not report API deaths separately for Kampucheans, Laotians, Pakistanis, and Tongans, so mortality rates were analyzed only for the remaining API groups.

Results

Overall cancer incidence rates for the API groups tended be lower than overall rates for non-Hispanic whites, with the exception of Native Hawaiian women (All cancers rate = 488.5 per 100,000 vs. 448.5 for non-Hispanic white women). Among the API groups, overall cancer incidence and death rates were highest for Native Hawaiian and Samoan men and women due to high rates for cancers of the prostate, lung, and colorectum among Native Hawaiian men; cancers of the prostate, lung, liver, and stomach among Samoan men; and cancers of the breast and lung among Native Hawaiian and Samoan women. Incidence and death rates for cancers of the liver, stomach, and nasopharynx were notably high in several of the API groups and exceeded rates generally seen for non-Hispanic white men and women. Incidence rates were lowest among Asian Indian/Pakistani and Guamanian men and women and Kampuchean women. Asian Indian and Guamanian men and women also had the lowest cancer death rates. Selected API groups had less favorable distributions of stage at diagnosis for certain cancers than non-Hispanic whites.

Conclusions

Possible disparities in cancer incidence or mortality between specific API groups in our study and non-Hispanic whites (referent group) were identified for several cancers. Unfavorable patterns of stage at diagnosis for cancers of the colon and rectum, breast, cervix uteri, and prostate suggest a need for cancer control interventions in selected groups. The observed variation in cancer patterns among API groups indicates the importance of monitoring these groups separately, as these patterns may provide etiologic clues that could be investigated by analytic epidemiological studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference U.S. Department of Health and Human Services (HHS) (2000) Healthy people 2010, 2nd edn. With understanding and improving health and objectives for improving health, 2 vols. U.S. Government Printing Office, Washington U.S. Department of Health and Human Services (HHS) (2000) Healthy people 2010, 2nd edn. With understanding and improving health and objectives for improving health, 2 vols. U.S. Government Printing Office, Washington
3.
go back to reference Glaser SL, Clarke CA, Gomez SL, O’Malley CD, Purdie D, West DW (2005) Cancer surveillance research: a vital subdiscipline of cancer epidemiology. Cancer Causes Control 16:1009–1019PubMedCrossRef Glaser SL, Clarke CA, Gomez SL, O’Malley CD, Purdie D, West DW (2005) Cancer surveillance research: a vital subdiscipline of cancer epidemiology. Cancer Causes Control 16:1009–1019PubMedCrossRef
5.
go back to reference Miller BA, Scoppa SM, Feuer EJ (2006) Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer 106:670–682PubMedCrossRef Miller BA, Scoppa SM, Feuer EJ (2006) Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer 106:670–682PubMedCrossRef
6.
go back to reference Kwong SL, Chen Jr. MS, Snipes KP, Bal DG, Wright WE (2005) Asian subgroups and cancer incidence and mortality rates in California. Cancer 104(Suppl):2975–2981PubMedCrossRef Kwong SL, Chen Jr. MS, Snipes KP, Bal DG, Wright WE (2005) Asian subgroups and cancer incidence and mortality rates in California. Cancer 104(Suppl):2975–2981PubMedCrossRef
7.
go back to reference Miller BA, Kolonel L, Bernstein L, Young JL, Swanson GM, West DW, Key CR, Liff JM, Glover CS, Alexander GA (eds) (1996) Racial/ethnic cancer patterns in the United States 1988--1992. National Cancer Institute, Bethesda, NIH Publ. No. 96-4104 Miller BA, Kolonel L, Bernstein L, Young JL, Swanson GM, West DW, Key CR, Liff JM, Glover CS, Alexander GA (eds) (1996) Racial/ethnic cancer patterns in the United States 1988--1992. National Cancer Institute, Bethesda, NIH Publ. No. 96-4104
8.
go back to reference McCracken M, Olsen M, Chen MS Jr, Jemal A, Thur M, Cokkinides V, Deapen D, Ward E (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57:190--205PubMedCrossRef McCracken M, Olsen M, Chen MS Jr, Jemal A, Thur M, Cokkinides V, Deapen D, Ward E (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57:190--205PubMedCrossRef
11.
go back to reference Johnson CH (ed) (2004) SEER program coding and staging manual 2004. National Cancer Institute, Bethesda, NIH Publication number 04-5581 Johnson CH (ed) (2004) SEER program coding and staging manual 2004. National Cancer Institute, Bethesda, NIH Publication number 04-5581
12.
go back to reference Lynch CF, Platz CE, Jones MP, Gazzaniga JM (1991) Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst 83:429--433PubMedCrossRef Lynch CF, Platz CE, Jones MP, Gazzaniga JM (1991) Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst 83:429--433PubMedCrossRef
13.
go back to reference Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) Appendix tables A-5, A-7. In: SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://www.seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007 Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) Appendix tables A-5, A-7. In: SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://​www.​seer.​cancer.​gov/​csr/​1975_​2003/​, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007
16.
go back to reference Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16:791--801CrossRef Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16:791--801CrossRef
17.
go back to reference Brillinger DR (1986) The natural variability of vital rates and associated statistics. Biometrics 42:693--734PubMedCrossRef Brillinger DR (1986) The natural variability of vital rates and associated statistics. Biometrics 42:693--734PubMedCrossRef
18.
go back to reference U.S. Cancer Statistics Working Group (2005) United States cancer statistics: 2002 incidence and mortality. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta U.S. Cancer Statistics Working Group (2005) United States cancer statistics: 2002 incidence and mortality. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
23.
go back to reference Surveillance, epidemiology, and end results (SEER) program (http://www.seer.cancer.gov) SEER*stat database: incidence—racial ethnic mono, SEER 18 (excl AZ,AK,RG) Limited Use, Nov 2005 for detailed API ethnicities only (1998–2002) <High 2000 Pops by 5> , National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission Surveillance, epidemiology, and end results (SEER) program (http://​www.​seer.​cancer.​gov) SEER*stat database: incidence—racial ethnic mono, SEER 18 (excl AZ,AK,RG) Limited Use, Nov 2005 for detailed API ethnicities only (1998–2002)  <High 2000 Pops by 5> , National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission
24.
go back to reference Surveillance, epidemiology, and end results (SEER) program (http://www.seer.cancer.gov) SEER*stat database: incidence—racial ethnic mono, SEER 18 (excl AZ,AK,RG) Limited Use, Nov 2005 for detailed API ethnicities only (1998–2002) <Low 2000 Pops by 5> , National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission Surveillance, epidemiology, and end results (SEER) program (http://​www.​seer.​cancer.​gov) SEER*stat database: incidence—racial ethnic mono, SEER 18 (excl AZ,AK,RG) Limited Use, Nov 2005 for detailed API ethnicities only (1998–2002)  <Low 2000 Pops by 5> , National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission
26.
go back to reference Braun KL, Tsark JU, Santos L, Aitaoto N, Chong C (2006) Building Native Hawaiian capacity in cancer research and programming. Cancer 107(S8):2082--2090PubMedCrossRef Braun KL, Tsark JU, Santos L, Aitaoto N, Chong C (2006) Building Native Hawaiian capacity in cancer research and programming. Cancer 107(S8):2082--2090PubMedCrossRef
27.
go back to reference Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) Introduction. In: SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://www.seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007 Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) Introduction. In: SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://​www.​seer.​cancer.​gov/​csr/​1975_​2003/​, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007
28.
go back to reference London WT and McGlynn KA (2006) Liver cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Inc., New York, pp 763--786 London WT and McGlynn KA (2006) Liver cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Inc., New York, pp 763--786
29.
go back to reference Kolonel LN, Wilkens LR (2006) Migrant studies. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Inc., New York, pp 189--201 Kolonel LN, Wilkens LR (2006) Migrant studies. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Inc., New York, pp 189--201
30.
go back to reference Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://www.seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007 Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2007) SEER cancer statistics review, 1975–2003. National Cancer Institute, Bethesda. http://​www.​seer.​cancer.​gov/​csr/​1975_​2003/​, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed Feb 2007
31.
go back to reference Yu MC, Yuan J-M (2006) Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni Jr JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press Inc, New York, pp 620--626 Yu MC, Yuan J-M (2006) Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni Jr JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press Inc, New York, pp 620--626
32.
go back to reference Hanley AJ, Choi BC, Holowaty EJ (1995) Cancer mortality among Chinese migrants: a review. Int J Epidemiol 24:255--265PubMedCrossRef Hanley AJ, Choi BC, Holowaty EJ (1995) Cancer mortality among Chinese migrants: a review. Int J Epidemiol 24:255--265PubMedCrossRef
33.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo, Thomas DB (eds) (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon Parkin DM, Whelan SL, Ferlay J, Teppo, Thomas DB (eds) (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon
34.
go back to reference Winter H, Cheng KK, Cummins C, Maric R, Silcocks P, Varghese C (1999) Cancer incidence in the south Asian population of England (1990--1992). Brit J Cancer 645--654 Winter H, Cheng KK, Cummins C, Maric R, Silcocks P, Varghese C (1999) Cancer incidence in the south Asian population of England (1990--1992). Brit J Cancer 645--654
35.
go back to reference Gomez SL, Le GM, Miller T, Undurraga DM, Shema SJ, Stroup A, Clark CA, Keegan THM, O'Malley CD, Unger Hu K, West DW, Glaser SL (2005) Cancer incidence among Asians in the Greater Bay Area, 1990--2002. Northern California Cancer Center, Fremont Gomez SL, Le GM, Miller T, Undurraga DM, Shema SJ, Stroup A, Clark CA, Keegan THM, O'Malley CD, Unger Hu K, West DW, Glaser SL (2005) Cancer incidence among Asians in the Greater Bay Area, 1990--2002. Northern California Cancer Center, Fremont
36.
go back to reference Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222--228PubMed Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222--228PubMed
37.
38.
go back to reference Sengupta A, Ghosh S, Bhattacharjee S, Das S (2004) Indian food ingredients and cancer prevention-an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pacific J Cancer Prev 5:126--132 Sengupta A, Ghosh S, Bhattacharjee S, Das S (2004) Indian food ingredients and cancer prevention-an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pacific J Cancer Prev 5:126--132
39.
go back to reference Howe HL, Wu X, Ries LAG, Cokkinides V, Ahmed F, Jemal A, Miller BA, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK (2006) Annual report to the nation on the status of cancer, 1975--2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107:1711--1742 Howe HL, Wu X, Ries LAG, Cokkinides V, Ahmed F, Jemal A, Miller BA, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK (2006) Annual report to the nation on the status of cancer, 1975--2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107:1711--1742
40.
go back to reference Mishra SI, Luce PH, Hubbell FA (2001) Breast cancer screening among American Samoan women. Prev Med 33:9--17PubMedCrossRef Mishra SI, Luce PH, Hubbell FA (2001) Breast cancer screening among American Samoan women. Prev Med 33:9--17PubMedCrossRef
41.
go back to reference Ishida DN, Toomata-Mayer TF, Braginsky NS (2001) Beliefs and attitudes of Samoan women toward early detection of breast cancer and mammography utilization. Cancer 91:262--266PubMedCrossRef Ishida DN, Toomata-Mayer TF, Braginsky NS (2001) Beliefs and attitudes of Samoan women toward early detection of breast cancer and mammography utilization. Cancer 91:262--266PubMedCrossRef
42.
go back to reference Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control 17:771--778PubMedCrossRef Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control 17:771--778PubMedCrossRef
43.
go back to reference Frost F, Taylor V, Fries E (1992) Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst 84:957--962PubMedCrossRef Frost F, Taylor V, Fries E (1992) Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst 84:957--962PubMedCrossRef
44.
go back to reference Swallen KC, West DW, Stewart SL, Glaser SL, Horn-Ross PL (1997) Predictors of misclassification of Hispanic ethnicity in a population-based cancer registry. Ann Epidemiol 7:200--206PubMedCrossRef Swallen KC, West DW, Stewart SL, Glaser SL, Horn-Ross PL (1997) Predictors of misclassification of Hispanic ethnicity in a population-based cancer registry. Ann Epidemiol 7:200--206PubMedCrossRef
45.
go back to reference Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW (1998) Adjustment of cancer incidence rates for ethnic misclassification. Biometrics 54:774--781PubMedCrossRef Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW (1998) Adjustment of cancer incidence rates for ethnic misclassification. Biometrics 54:774--781PubMedCrossRef
46.
go back to reference Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ (1998) Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis 8:218--227PubMed Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ (1998) Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis 8:218--227PubMed
47.
go back to reference Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW (1999) Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol 149:1063--1071PubMed Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW (1999) Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol 149:1063--1071PubMed
48.
go back to reference Rosenberg HM, Maurer JD, Sorlie PD, Johnson NJ, MacDorman MF, Hoyert DL, Spitler JF, Scott C (1999) Quality of death rates by race and Hispanic origin: a summary of current research, 1999. National Center for Health Statistics. Vital Health Stat 128:1--13 Rosenberg HM, Maurer JD, Sorlie PD, Johnson NJ, MacDorman MF, Hoyert DL, Spitler JF, Scott C (1999) Quality of death rates by race and Hispanic origin: a summary of current research, 1999. National Center for Health Statistics. Vital Health Stat 128:1--13
Metadata
Title
Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
Authors
Barry A. Miller
Kenneth C. Chu
Benjamin F. Hankey
Lynn A. G. Ries
Publication date
01-04-2008
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9088-3

Other articles of this Issue 3/2008

Cancer Causes & Control 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine